Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Business Strategy for the Professional Academic

Publication date: Mar 20, 2012 12:53 PM

Start: May 24, 2012 10:00 AM
End: May 25, 2012 04:00 PM

Location: The Moller Centre, Cambridge

Training

Academics are increasingly being expected to demonstrate the impact of their research and engage with business and external agencies.

They need strategies to help realise the potential of their research for major social or economic benefit.

This short course provides essential frameworks and strategies for articulating and amplifying the impact of research outputs. The course is based around real case studies and situations drawn from a wide variety of disciplines and industries. It covers a similarly broad range of ‘impacts’, from social and collaborative models through to new ‘for-profit spin-outs’. The sessions are highly interactive – with an emphasis on helping academics to apply innovation frameworks and business strategies within their own context.

For more information and a copy of the course programme please visit the PraxisUnico website.